Trade Harmony Biosciences Stock – Advancing Treatments for Rare Neurological Conditions

Harmony Biosciences Holdings Inc. (NASDAQ: HRMY) is a biopharmaceutical company focused on developing therapies for rare neurological disorders, including narcolepsy. Its lead product, WAKIX, addresses unmet needs in sleep-wake regulation. Traded under the symbol HRMY, it operates in the healthcare sector and is favored by investors seeking growth in targeted neuroscience treatment markets.